Emboline, Inc. Completes Funding Of Over $10 Million

Combination of $3 Million in Equity Financing and Conversion of $7 Million in Convertible Notes will Fund Clinical Trial for the Emboliner™ Embolic Protection Catheter

SANTA CRUZ, Calif., April 19, 2018 -- (Healthcare Sales & Marketing Network) -- Embo... Devices, Interventional, Cardiology, Venture Capital Emboline, Emboliner, Embolic Protection, TAVR

Source: HSMN NewsFeed - April 19, 2018 Category: Pharmaceuticals Source Type: news